Cite
Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab.
MLA
Wu, Yuemeng, et al. “Serum Biomarker-Based Endotypes of Atopic Dermatitis in China and Prediction for Efficacy of Dupilumab.” British Journal of Dermatology, vol. 188, no. 5, May 2023, pp. 649–60. EBSCOhost, https://doi.org/10.1093/bjd/ljad032.
APA
Wu, Y., Gu, C., Wang, S., Yin, H., Qiu, Z., Luo, Y., Li, Z., Wang, C., Yao, X., & Li, W. (2023). Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab. British Journal of Dermatology, 188(5), 649–660. https://doi.org/10.1093/bjd/ljad032
Chicago
Wu, Yuemeng, Chaoying Gu, Shangshang Wang, Huibin Yin, Zhuoqiong Qiu, Yang Luo, Zheng Li, Ce Wang, Xu Yao, and Wei Li. 2023. “Serum Biomarker-Based Endotypes of Atopic Dermatitis in China and Prediction for Efficacy of Dupilumab.” British Journal of Dermatology 188 (5): 649–60. doi:10.1093/bjd/ljad032.